Results 91 to 94 of about 256 (94)

Leptin in debelost - nevroendokrini, presnovni in aterogeni učinki leptina: Leptin and obesity - neuroendocrine, metabolic and atherogenic effects of leptin:

2003
Background. Leptin is an adipocyte-derived hormone that was recently discovered. Leptin and leptin resistance play an important role in the pathogenesis of obesity. Leptin acts by binding to specific receptors in the hypothalamus to alter the expression of several neuropeptides that regulate food intake and energy expenditure.
Mavri, Alenka, Šabovič, Mišo
openaire   +1 more source

Hormon stradanja fibroblastni rastni dejavnik 21 - novo zdravilo za debelost in metabolni sindrom?: Fasting hormone fibroblast growth factor 21 - new therapy for obesity and metabolic syndrome?:

2009
Increasing prevalence of metabolic diseases is alarming and highlights the need for more effective and safer therapies. Current recommendations for therapy for metabolic syndrome focus on corrections of the individual components. Fibrates are used to treat hyperlipidemia as a predisposing factorto metabolic syndrome and cardiovascular disease. Fibrates
openaire   +1 more source

Morbidna debelost – akutni abdomen in zapleti po bariatričnih posegih

openaire   +1 more source

Debelost - javnozdravstveni problem delovne populacije: Public health problem of the workforce:

2018
openaire   +1 more source